These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3707714

  • 1. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.
    Neuenhofer S, Conzelmann E, Schwarzmann G, Egge H, Sandhoff K.
    Biol Chem Hoppe Seyler; 1986 Mar; 367(3):241-4. PubMed ID: 3707714
    [Abstract] [Full Text] [Related]

  • 2. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
    Rosengren B, Månsson JE, Svennerholm L.
    J Neurochem; 1987 Sep; 49(3):834-40. PubMed ID: 3612128
    [Abstract] [Full Text] [Related]

  • 3. Enzyme-linked immunosorbent assay for the ganglioside GM2-activator protein. Screening of normal human tissues and body fluids, of tissues of GM2 gangliosidosis, and for its subcellular localization.
    Banerjee A, Burg J, Conzelmann E, Carroll M, Sandhoff K.
    Hoppe Seylers Z Physiol Chem; 1984 Mar; 365(3):347-56. PubMed ID: 6724528
    [Abstract] [Full Text] [Related]

  • 4. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
    Kodama T, Togawa T, Tsukimura T, Kawashima I, Matsuoka K, Kitakaze K, Tsuji D, Itoh K, Ishida Y, Suzuki M, Suzuki T, Sakuraba H.
    PLoS One; 2011 Mar; 6(12):e29074. PubMed ID: 22205997
    [Abstract] [Full Text] [Related]

  • 5. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses.
    Kobayashi T, Goto I, Okada S, Orii T, Ohno K, Nakano T.
    J Neurochem; 1992 Oct; 59(4):1452-8. PubMed ID: 1402895
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
    Taniike M, Inui K, Hirabayashi Y, Tsukamoto H, Nishimoto J, Midorikawa M, Okada S, Yabuuchi H.
    J Inherit Metab Dis; 1989 Oct; 12 Suppl 2():372-4. PubMed ID: 2512447
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of some minor gangliosides in Tay-Sachs brains.
    Yu RK, Itoh T, Yohe HC, Macala LJ.
    Brain Res; 1983 Sep 19; 275(1):47-52. PubMed ID: 6414648
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Presence of an unusual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain.
    Li YT, Maskos K, Chou CW, Cole RB, Li SC.
    J Biol Chem; 2003 Sep 12; 278(37):35286-91. PubMed ID: 12829702
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Identification of GM2-gangliosidosis using an in vitro loading test].
    Akhunov VS, Krasnopol'skaia KD.
    Vopr Med Khim; 1987 Sep 12; 33(4):115-9. PubMed ID: 3116767
    [Abstract] [Full Text] [Related]

  • 12. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
    Demir SA, Timur ZK, Ateş N, Martínez LA, Seyrantepe V.
    J Neuroinflammation; 2020 Sep 20; 17(1):277. PubMed ID: 32951593
    [Abstract] [Full Text] [Related]

  • 13. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease.
    Chen Y, Allegood J, Liu Y, Wang E, Cachón-Gonzalez B, Cox TM, Merrill AH, Sullards MC.
    Anal Chem; 2008 Apr 15; 80(8):2780-8. PubMed ID: 18314967
    [Abstract] [Full Text] [Related]

  • 14. Prenatal diagnosis of GM2-gangliosidosis. Immunofluorescence analysis of ganglioside GM2 in cultured amniocytes by confocal laser scanning microscopy.
    Sakuraba H, Itoh K, Kotani M, Tai T, Yamada H, Kurosawa K, Kuroki Y, Suzuki H, Utsunomiya T, Inoue H.
    Brain Dev; 1993 Apr 15; 15(4):278-82. PubMed ID: 8250149
    [Abstract] [Full Text] [Related]

  • 15. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
    Raghavan S, Krusell A, Lyerla TA, Bremer EG, Kolodny EH.
    Biochim Biophys Acta; 1985 Apr 25; 834(2):238-48. PubMed ID: 3995063
    [Abstract] [Full Text] [Related]

  • 16. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G, Harden A.
    Neuropediatrics; 1984 Sep 25; 15 Suppl():74-84. PubMed ID: 6100798
    [Abstract] [Full Text] [Related]

  • 17. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
    Akhunov VS, Mirenburg TV, Krasnopolskaya XD.
    J Inherit Metab Dis; 1994 Sep 25; 17(1):104-11. PubMed ID: 8051915
    [Abstract] [Full Text] [Related]

  • 18. Preparation of various lysogangliosides including lyso-fucosyl GM1 and delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis.
    Taketomi T, Hara A, Uemura K, Kurahashi H, Sugiyama E.
    J Biochem; 1997 Feb 25; 121(2):264-9. PubMed ID: 9089399
    [Abstract] [Full Text] [Related]

  • 19. Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis).
    Suzuki K, Chen GC.
    J Lipid Res; 1967 Mar 25; 8(2):105-13. PubMed ID: 14564716
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry.
    Gu J, Tifft CJ, Soldin SJ.
    Clin Biochem; 2008 Apr 25; 41(6):413-7. PubMed ID: 18241673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.